PLCO Publications
Here you can browse the complete list of publications for PLCO
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| Serum Concentrations of Per- and Polyfluoroalkyl Substances and Risk of Renal Cell Carcinoma. | 32944748 | Shearer JJ, Callahan CL, Calafat AM, Huang WY, Jones RR, Sabbisetti VS, Freedman ND, Sampson JN, Silverman DT, Purdue MP, Hofmann JN | Journal of the National Cancer Institute | 2020 | PLCO |
| Association study between genetic variants in retinol metabolism pathway genes and prostate cancer risk. | 33068330 | Cao D, Meng Y, Li S, Xin J, Ben S, Cheng Y, Wang M, Hua L, Cheng G | Cancer Med | 2020 | PLCO |
| THBS2/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement. | 33067248 | Udgata S, Takenaka N, Bamlet WR, Oberg AL, Yee SS, Carpenter EL, Herman D, Kim J, Petersen GM, Zaret KS | Cancer Prev Res (Phila) | 2020 | PLCO |
| Generalizability of Prostate-Specific Antigen (PSA) Screening Trials in a "Real World" Setting: A Nationwide Survey Analysis. | 33221417 | Dalela D, Sood A, Keeley J, Rogers C, Menon M, Abdollah F | Urology | 2020 | PLCO |
| Fatherhood status in relation to prostate cancer risks in two large U.S.-based prospective cohort studies. | 33219755 | Geczik AM, Kelly SP, Pfeiffer RM, Huang WY, Liao LM, Zhou CK, Brinton LA, Cook MB | Cancer Med | 2020 | PLCO |
| Blunted PTH response to vitamin D insufficiency/deficiency and colorectal neoplasia risk. | 33190990 | Hellwege JN, Zhu X, Huang X, Shrubsole MJ, Fan L, Li B, Ness R, Seidner DL, Giovannucci EL, Edwards TL, Dai Q | Clin Nutr | 2020 | PLCO |
| Other and All-Cause Mortality among Men Diagnosed with Prostate Cancer in the PLCO Trial. | 33350321 | Pierre-Victor D, Pinsky PF, Miller E, Parnes H | J Urol | 2020 | PLCO |
| A prospective study of the associations among fine particulate matter, genetic variants, and the risk of colorectal cancer. | 33338681 | Chu H, Xin J, Yuan Q, Wu Y, Du M, Zheng R, Liu H, Wu S, Zhang Z, Wang M | Environ Int | 2020 | PLCO |
| Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection. | 33333055 | Fahrmann JF, Schmidt CM, Mao X, Irajizad E, Loftus M, Zhang J, Patel N, Vykoukal J, Dennison JB, Long JP, Do KA, Zhang J, Chabot JA, Kluger MD, Kastrinos F, Brais L, Babic A, Jajoo K, Lee LS, Clancy TE, Ng K, Bullock A, Genkinger J, Yip-Schneider MT… | Gastroenterology | 2020 | PLCO |
| Weight calibration to improve efficiency for estimating pure risks from the additive hazards model with the nested case-control design. | 33270907 | Shin YE, Pfeiffer RM, Graubard BI, Gail MH | Biometrics | 2020 | PLCO |
| Association of Combined Sero-Positivity to Helicobacter pylori and Streptococcus gallolyticus with Risk of Colorectal Cancer. | 33143263 | Epplein M, Le Marchand L, Cover TL, Song M, Blot WJ, Peek RM, Teras LR, Visvanathan K, Chen Y, Sesso HD, Zeleniuch-Jacquotte A, Berndt SI, Potter JD, Ryser MD, Haiman CA, Wassertheil-Smoller S, Tinker LF, Waterboer T, Butt J | Microorganisms | 2020 | PLCO |
| Racial Differences in Helicobacter pylori CagA Sero-prevalence in a Consortium of Adult Cohorts in the United States. | 32856604 | Varga MG, Butt J, Blot WJ, Le Marchand L, Haiman CA, Chen Y, Wassertheil-Smoller S, Tinker LF, Peek RM, Potter JD, Cover TL, Hyslop T, Zeleniuch-Jacquotte A, Berndt SI, Hildesheim A, Waterboer T, Pawlita M, Epplein M | Cancer Epidemiol Biomarkers Prev | 2020 | PLCO |
| A Prospective Study of Circulating Chemokines and Angiogenesis Markers and Risk of Multiple Myeloma and Its Precursor. | 33336146 | Hofmann JN, Landgren O, Landy R, Kemp TJ, Santo L, McShane CM, Shearer JJ, Lan Q, Rothman N, Pinto LA, Pfeiffer RM, Hildesheim A, Katki HA, Purdue MP | JNCI Cancer Spectr | 2020 | PLCO |
| Gender Differences in Factors Associated with Clinically Meaningful Weight Loss among Adults Who Were Overweight or Obese: A Population-Based Cohort Study. | 33352568 | Li JB, Qiu ZY, Liu Z, Zhou Q, Feng LF, Li JD, Zhang X | Obes Facts | 2020 | PLCO |
| Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study. | 33327948 | Bull CJ, Bell JA, Murphy N, Sanderson E, Davey Smith G, Timpson NJ, Banbury BL, Albanes D, Berndt SI, Bézieau S, Bishop DT, Brenner H, Buchanan DD, Burnett-Hartman A, Casey G, Castellví-Bel S, Chan AT, Chang-Claude J, Cross AJ, de la Chapelle A, Fig… | BMC Med | 2020 | PLCO |
| Identifying Novel Susceptibility Genes for Colorectal Cancer Risk From a Transcriptome-Wide Association Study of 125,478 Subjects. | 33058866 | Guo X, Lin W, Wen W, Huyghe J, Bien S, Cai Q, Harrison T, Chen Z, Qu C, Bao J, Long J, Yuan Y, Wang F, Bai M, Abecasis GR, Albanes D, Berndt SI, Bézieau S, Bishop DT, Brenner H, Buch S, Burnett-Hartman A, Campbell PT, Castellví-Bel S, Chan AT, Chang… | Gastroenterology | 2020 | PLCO |
| Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses. | 32878631 | Seyed Khoei N, Jenab M, Murphy N, Banbury BL, Carreras-Torres R, Viallon V, Kühn T, Bueno-de-Mesquita B, Aleksandrova K, Cross AJ, Weiderpass E, Stepien M, Bulmer A, Tjønneland A, Boutron-Ruault MC, Severi G, Carbonnel F, Katzke V, Boeing H, Bergman… | BMC Med | 2020 | PLCO |
| Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk. | 32758450 | Thomas M, Sakoda LC, Hoffmeister M, Rosenthal EA, Lee JK, van Duijnhoven FJB, Platz EA, Wu AH, Dampier CH, de la Chapelle A, Wolk A, Joshi AD, Burnett-Hartman A, Gsur A, Lindblom A, Castells A, Win AK, Namjou B, Van Guelpen B, Tangen CM, He Q, Li CI… | Am J Hum Genet | 2020 | PLCO |
| Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers. | 32620889 | Zhang YD, Hurson AN, Zhang H, Choudhury PP, Easton DF, Milne RL, Simard J, Hall P, Michailidou K, Dennis J, Schmidt MK, Chang-Claude J, Gharahkhani P, Whiteman D, Campbell PT, Hoffmeister M, Jenkins M, Peters U, Hsu L, Gruber SB, Casey G, Schmit SL,… | Nat Commun | 2020 | PLCO |
| Postmenopausal Hormone Therapy and Colorectal Cancer Risk by Molecularly Defined Subtypes and Tumor Location. | 32923935 | Labadie JD, Harrison TA, Banbury B, Amtay EL, Bernd S, Brenner H, Buchanan DD, Campbell PT, Cao Y, Chan AT, Chang-Claude J, English D, Figueiredo JC, Gallinger SJ, Giles GG, Gunter MJ, Hoffmeister M, Hsu L, Jenkins MA, Lin Y, Milne RL, Moreno V, Mur… | JNCI Cancer Spectr | 2020 | PLCO |